Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hyaluronidase-facilitated subcutaneous immunoglobulin 10% as maintenance therapy for chronic inflammatory demyelinating polyradiculoneuropathy: The ADVANCE-CIDP 1 randomized controlled trial.
Bril V, Hadden RDM, Brannagan TH 3rd, Bar M, Chroni E, Rejdak K, Rivero A, Andersen H, Latov N, Levine T, Pasnoor M, Sacconi S, Souayah N, Anderson-Smits C, Duff K, Greco E, Hasan S, Li Z, Yel L, Ay H. Bril V, et al. Among authors: anderson smits c. J Peripher Nerv Syst. 2023 Sep;28(3):436-449. doi: 10.1111/jns.12573. Epub 2023 Jul 6. J Peripher Nerv Syst. 2023. PMID: 37314318 Clinical Trial.
Early Diagnosis of Primary Immunodeficiency Disease Using Clinical Data and Machine Learning.
Mayampurath A, Ajith A, Anderson-Smits C, Chang SC, Brouwer E, Johnson J, Baltasi M, Volchenboum S, Devercelli G, Ciaccio CE. Mayampurath A, et al. Among authors: anderson smits c. J Allergy Clin Immunol Pract. 2022 Nov;10(11):3002-3007.e5. doi: 10.1016/j.jaip.2022.08.041. Epub 2022 Sep 13. J Allergy Clin Immunol Pract. 2022. PMID: 36108921 Free article.
Update on real-world use of facilitated subcutaneous immunoglobulin and immune globulin subcutaneous (human) 20% solution in patients with immunodeficiencies: poster extracts from the 19th Biennial Meeting of the European Society for Immunodeficiencies.
Borte M, Anderson-Smits C, Hermann C. Borte M, et al. Among authors: anderson smits c. Expert Rev Clin Immunol. 2021 Apr;17(sup1):7-8. doi: 10.1080/1744666X.2021.1913122. Epub 2021 May 26. Expert Rev Clin Immunol. 2021. PMID: 33908818
Long-term safety and tolerability of hyaluronidase-facilitated subcutaneous immunoglobulin 10% as maintenance therapy for chronic inflammatory demyelinating polyradiculoneuropathy: Results from the ADVANCE-CIDP 3 trial.
Hadden RDM, Andersen H, Bril V, Basta I, Rejdak K, Duff K, Greco E, Hasan S, Anderson-Smits C, Ay H. Hadden RDM, et al. Among authors: anderson smits c. J Peripher Nerv Syst. 2024 Nov 11. doi: 10.1111/jns.12672. Online ahead of print. J Peripher Nerv Syst. 2024. PMID: 39523874
19 results